Related Experiment Videos
Contribution of anticholinergic medication to symptom change in schizophrenia
The Journal of Clinical Psychiatry
|September 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.
Schizophrenia research·2000
Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study.
Schizophrenia research·2000
Symptom correlates of global measures of severity in schizophrenia.
Comprehensive psychiatry·1999
Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry·1999
Electroconvulsive treatment of a bipolar adolescent postcraniotomy for brain stem astrocytoma.
Journal of child and adolescent psychopharmacology·1999
Using Speech to Develop Multivariable Prediction Models for Major Depressive Disorder and Generalized Anxiety Disorder During Pregnancy.
The Journal of clinical psychiatry·2026
Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages: A Cross-Sectional Cohort Study.
The Journal of clinical psychiatry·2026
Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder.
The Journal of clinical psychiatry·2026
Electroconvulsive Therapy and All-Cause Mortality, Nonsuicide Mortality, and Suicide Mortality.
The Journal of clinical psychiatry·2026
Pharmacotherapies for Co-Occurring Stimulant Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Network Meta-Analysis.
The Journal of clinical psychiatry·2026
Time Trends in Maternal Attention-Deficit/Hyperactivity Disorder and Medication Use in Pregnancy.
The Journal of clinical psychiatry·2026
Mechanisms of NMDA receptor inhibition by fluoroethylnormemantine - comparison with memantine.
European journal of pharmacology·2026
Schisandrol A in Fufang Muniziqi Granules suppresses the abnormal expression of MHC-II in renal tubular epithelial cells to treat lupus nephritis through disrupting the interaction between STUB1 and PPARγ.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026